The results demonstrated that HMGB2 silencing markedly enhanced NK cell-mediated cytotoxicity against ESCC cells, as indicated by increased tumor cell killing and elevated cytokine production (Figure 4e). The gene discussed is HMGB2; the disease is esophageal squamous cell carcinoma.